Begin main content

David Agnew Appointed Chair of the CADTH Board of Directors

August 9, 2018
CADTH is pleased to announce the appointment of Mr. David Agnew to Chair of the CADTH Board of Directors, effective July 10, 2018. Mr. Agnew has led a distinguished career as an executive and senior leader in the public, private, and non-profit sectors. He is currently the President of Seneca College, one of the largest colleges in Canada. His d...

New from CADTH: Pharmaceutical Reviews Update

August 9, 2018
CADTH is pleased to announce the launch of its new Pharmaceutical Reviews Update newsletter.   The Pharmaceutical Reviews Update consolidates our CDR Update, pCODR Update, Therapeutic Review Update, and Updates for Patient Groups into a single newsletter.  It will make it easier for you to stay on top of changes to our review processes, and redu...

Call for Patient Input: Jublia

July 4, 2018
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Jublia Brand name Generic name Manufacturer In...